{"name":"Foundation Medicine","permalink":"foundation-medicine","crunchbase_url":"http://www.crunchbase.com/company/foundation-medicine","homepage_url":"http://www.foundationmedicine.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"dna-sequencing, diagnostic-tests","alias_list":"","email_address":"info@foundationmedicine.com","phone_number":"617-418-2200","description":"Genetic sequencing lab tests","created_at":"Mon Apr 19 15:52:26 UTC 2010","updated_at":"Fri Sep 21 02:14:54 UTC 2012","overview":"<p>Foundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.</p>","image":{"available_sizes":[[[150,84],"assets/images/resized/0013/4432/134432v1-max-150x150.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-250x250.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President and CEO","person":{"first_name":"Michael","last_name":"J. Pellini","permalink":"michael-j-pellini","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$76M","funding_rounds":[{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/foundation-medicine-closes-33-5m-expanded-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Foundation Medicine Closes $33.5M Expanded Series A Financing","raised_amount":33500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":18,"investments":[{"company":null,"financial_org":{"name":"Third Rock Ventures","permalink":"third-rock-ventures-2","image":{"available_sizes":[[[150,78],"assets/images/resized/0005/0700/50700v1-max-150x150.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-250x250.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Kleiner Perkins Caufield & Byers","permalink":"kleiner-perkins-caufield-byers","image":{"available_sizes":[[[150,150],"assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],[[250,250],"assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],[[450,450],"assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Google Ventures","permalink":"google-ventures","image":{"available_sizes":[[[150,70],"assets/images/resized/0003/9829/39829v8-max-150x150.jpg"],[[250,116],"assets/images/resized/0003/9829/39829v8-max-250x250.jpg"],[[450,210],"assets/images/resized/0003/9829/39829v8-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://www.finsmes.com/2012/09/foundation-medicine-closes-42-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Foundation Medicine Closes $42.5M Series B Funding","raised_amount":42500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":20,"investments":[{"company":{"name":"Deerfield Management ","permalink":"deerfield-management","image":null},"financial_org":null,"person":null},{"company":null,"financial_org":{"name":"Casdin Capital","permalink":"casdin-capital","image":{"available_sizes":[[[150,43],"assets/images/resized/0021/8617/218617v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0021/8617/218617v1-max-250x250.jpg"],[[450,129],"assets/images/resized/0021/8617/218617v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Redmile Group","permalink":"redmile-group","image":null},"person":null},{"company":null,"financial_org":{"name":"Roche Venture Fund","permalink":"roche-venture-fund","image":{"available_sizes":[[[150,21],"assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],[[156,22],"assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],[[156,22],"assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Third Rock Ventures","permalink":"third-rock-ventures-2","image":{"available_sizes":[[[150,78],"assets/images/resized/0005/0700/50700v1-max-150x150.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-250x250.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Google Ventures","permalink":"google-ventures","image":{"available_sizes":[[[150,70],"assets/images/resized/0003/9829/39829v8-max-150x150.jpg"],[[250,116],"assets/images/resized/0003/9829/39829v8-max-250x250.jpg"],[[450,210],"assets/images/resized/0003/9829/39829v8-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Kleiner Perkins Caufield & Byers","permalink":"kleiner-perkins-caufield-byers","image":{"available_sizes":[[[150,150],"assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],[[250,250],"assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],[[450,450],"assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"One Kendall Square","address2":"Suite B3501","zip_code":"02139 ","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"has appointed Maureen Cronin in the newly created role of senior vice president of research and product development","stoned_year":2010,"stoned_month":11,"stoned_day":12,"source_url":"http://www.masshightech.com/stories/2010/11/08/daily56-Foundation-Medicine-names-Cronin-as-new-SVP.html","source_text":null,"source_description":"Foundation Medicine names Cronin as new SVP","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Foundation Medicine","permalink":"foundation-medicine"}},{"description":"has inked a collaboration deal with Swiss drug giant Novartis AG to tailor Foundationâ€™s genome-based tests to Novartisâ€™ needs","stoned_year":2011,"stoned_month":1,"stoned_day":4,"source_url":"http://www.masshightech.com/stories/2011/01/03/daily22-Foundation-Medicine-Novartis-team-up-on-cancer-diagnostics.html","source_text":null,"source_description":"Foundation Medicine, Novartis team up on cancer diagnostics","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Foundation Medicine","permalink":"foundation-medicine"}},{"description":"has named Gary Palmer as senior vice president, medical affairs and commercial development","stoned_year":2011,"stoned_month":1,"stoned_day":19,"source_url":"http://www.masshightech.com/stories/2011/01/17/daily28-Foundation-Medicine-appoints-Palmer-to-new-VP-role.html","source_text":null,"source_description":"Foundation Medicine appoints Palmer to new VP role","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Foundation Medicine","permalink":"foundation-medicine"}}],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}